Literature DB >> 5971569

Biologically active metabolite of vitamin D3 from bone, liver, and blood serum.

J Lund, H F DeLuca.   

Abstract

Radioactive metabolites present in bone, blood, liver, and feces of rats given (3)H vitamin D(3) have been isolated. Of these the aqueous soluble metabolite(s) from tissue and all those isolated from feces did not cure rickets in rats, while all the others were at least partially active in this regard. One of the metabolites proved to be as active as the parent vitamin in curing rickets and was found in large amounts in liver, blood, and bone. As much as 50-80% of the radioactivity in bone was found in this metabolite after a 500 IU oral dose of (3)H vitamin D(3). With 10 IU doses of 1,2-(3)H vitamin D(3), most of the radioactivity of the organs examined was found in this metabolite fraction. This metabolite appears to be more polar than vitamin D and is not an esterified form of the vitamin nor a complex of the vitamin with tissue lipids. Its possible role as the metabolically active form of the vitamin is discussed.

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 5971569

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  60 in total

1.  25-Hydroxyvitamin D3 regulation.

Authors:  M B Clark; J T Potts
Journal:  Calcif Tissue Res       Date:  1977-05

2.  The use of an isolated perfused liver to study the control of cholecalciferol-25-hydroxylase activity in the rat.

Authors:  E B Mawer; A Reeve
Journal:  Calcif Tissue Res       Date:  1977-05

3.  Comparative studies on the 25-hydroxylations of cholecalciferol and 1 alpha-hydroxycholecalfierol in perfused rat liver.

Authors:  M Fukushima; Y Nishil; M Suzuki; T Suda
Journal:  Biochem J       Date:  1978-03-15       Impact factor: 3.857

Review 4.  The clinical use of vitamin D metabolites and their potential developments: a position statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).

Authors:  Luisella Cianferotti; Claudio Cricelli; John A Kanis; Ranuccio Nuti; Jean-Y Reginster; Johann D Ringe; Rene Rizzoli; Maria Luisa Brandi
Journal:  Endocrine       Date:  2015-05-01       Impact factor: 3.633

5.  Kinetic analysis of 25-hydroxyvitamin D3 metabolism in strontium-induced rickets in the chick.

Authors:  J L Omdahl; G Jelinek; R P Eaton
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

6.  Maintenance by cortisone of the calcemic response to parathyroid extract of rats on a diet without vitamin D and low in calcium.

Authors:  H Pavlovitch; G Witmer; J Bertret; V Presle; S Balsan
Journal:  Calcif Tissue Res       Date:  1976-06-14

7.  Current status of vitamin D metabolism.

Authors:  A Fairney
Journal:  Proc R Soc Med       Date:  1977-02

8.  Metabolism of 1,25-dihydroxycholecalciferol in the rat.

Authors:  C A Frolik; H F DeLuca
Journal:  J Clin Invest       Date:  1972-11       Impact factor: 14.808

9.  Hyperparathyroidism in hepatobiliary disease in infancy.

Authors:  A Kobayashi; S Kawai; T Utsunomiya; Y Ohbe
Journal:  Eur J Pediatr       Date:  1975-12-09       Impact factor: 3.183

10.  In vitro production of 1,25-dihydroxyvitamin D3 by rat placental tissue.

Authors:  Y Tanaka; B Halloran; H K Schnoes; H F DeLuca
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.